Chargement en cours...
Duration of anticoagulant therapy and VTE recurrence in patients with cancer
PURPOSE: Anticoagulant therapy for at least 3–6 months is currently recommended for treatment of venous thromboembolism (VTE) in patients with cancer, but the optimal duration of treatment is unknown. This study examines the association between the duration of anticoagulation treatment and VTE recur...
Enregistré dans:
| Publié dans: | Support Care Cancer |
|---|---|
| Auteurs principaux: | , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer Berlin Heidelberg
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6726708/ https://ncbi.nlm.nih.gov/pubmed/30734088 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-019-4661-3 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|